AH Equity Partners Bio II, L.L.C.

AH Equity Partners Bio II, L.L.C. is listed in filings as 10% Owner at Nautilus Biotechnology, Inc.. This profile follows SEC Form 4 activity through Jun 4, 2026, including sale activity. Recent filings connect the profile to Nautilus Biotechnology, Inc. (NAUT). The current snapshot covers public activity from Jun 4, 2026. Reported amounts are shown as $902.5K to $10.8M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.